Literature DB >> 12443661

Detection of residual pertussis toxin in vaccines using a modified ribosylation assay.

Chun-Ting Yuen1, Catpagavalli Canthaboo, J Alan Menzies, Terry Cyr, Larry W Whitehouse, Chris Jones, Michael J Corbel, Dorothy Xing.   

Abstract

Pertussis toxin (PTx) in its detoxified form is an important component of both whole cell and acellular pertussis vaccines (ACVs). For safety reasons, it is imperative to ensure that the quantity of residual PTx in vaccines does not exceed permissible levels. The majority of the toxic effects of PTx have been attributed to the consequences of PTx-catalyzed ribosylation of the alpha-subunits of signal-transducing guanine-nucleotide-binding proteins. In this report PTx ribosylation activity was determined by an improved enzymatic-high performance liquid chromatography coupled assay using a fluorescein labeled Galpha(i3)C20 peptide. The effect of aluminum salts and other vaccine components on the assay system were also studied. The enzymatic assay system was shown to be a convenient, sensitive method and correlate well with the toxicity observed in vivo by the histamine sensitization assay. This method forms the basis of a new assay which could replace the unsatisfactory animal test currently used in pertussis vaccines control.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12443661     DOI: 10.1016/s0264-410x(02)00446-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Confocal microscopy study of pertussis toxin and toxoids on CHO-cells.

Authors:  Yajun Tan; Roland A Fleck; Catpagavalli Asokanathan; Chun-Ting Yuen; Dorothy Xing; Shumin Zhang; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

2.  Investigation in a murine model of possible mechanisms of enhanced local reactions to post-primary diphtheria-tetanus toxoid boosters in recipients of acellular pertussis-diphtheria-tetanus vaccine.

Authors:  Masaki Ochiai; Yoshinobu Horiuchi; Chun-Ting Yuen; Catpagavalli Asokanathan; Akihiko Yamamoto; Kenji Okada; Michiyo Kataoka; Kevin Markey; Michael Corbel; Dorothy Xing
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  Toward a mechanism-based in vitro safety test for pertussis toxin.

Authors:  Stefan F C Vaessen; Martijn W P Bruysters; Rob J Vandebriel; Saertje Verkoeijen; Rogier Bos; Cyrille A M Krul; Arnoud M Akkermans
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

Review 4.  Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.

Authors:  Kevin Markey; Catpagavalli Asokanathan; Ian Feavers
Journal:  Toxins (Basel)       Date:  2019-07-17       Impact factor: 4.546

Review 5.  In Vivo Models and In Vitro Assays for the Assessment of Pertussis Toxin Activity.

Authors:  Marieke Esther Hoonakker
Journal:  Toxins (Basel)       Date:  2021-08-12       Impact factor: 4.546

6.  Cloning and Expression of S1 Subunit of Pertussis Toxin in Escherichia coli.

Authors:  Abolfazl Khafri; Khosrow Aghaiypour; Shahin Najar Peerayeh; Reihaneh Ghorbani
Journal:  Avicenna J Med Biotechnol       Date:  2011-01

7.  Safety testing of acellular pertussis vaccines: Use of animals and 3Rs alternatives.

Authors:  Marieke Hoonakker; Juan Arciniega; Coenraad Hendriksen
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.